A PhaseⅠRandomised, Double-blind, Placebo-controlled, Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Characteristics of the Oral Topical Use of GB001 Recombinant Peptide Spray in Chinese Healthy Adult Subjects
This trial is conducted in China. The aim of this clinical trial is to assess the safety , tolerability and pharmacokinetics profiles of GB001 by single ascending dose and multiple ascending doses in healthy subjects after topical buccal delivery.
100 项与 Zhejiang Echon Biopharm Limited 相关的临床结果
0 项与 Zhejiang Echon Biopharm Limited 相关的专利(医药)
100 项与 Zhejiang Echon Biopharm Limited 相关的药物交易
100 项与 Zhejiang Echon Biopharm Limited 相关的转化医学